Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Threonine proteases are a family of proteolytic enzymes that utilize a threonine residue at their active site for peptide bond cleavage. The most well-known members are the catalytic subunits of the proteasome, essential for regulated protein degradation. These enzymes play crucial roles in protein turnover, cell growth, immune responses, and metabolism, and are implicated in diseases such as cancer and neurodegenerative disorders.
Threonine proteases cleave peptide bonds via a two-step catalytic mechanism involving an N-terminal threonine residue acting as a nucleophile and general base, forming an acyl-enzyme intermediate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Threonine Protease.